Genentech USA Inc - Company Profile
Powered by
All the data and insights you need on Genentech USA Inc in one report.
- Save hours of research time and resources with
our up-to-date Genentech USA Inc Strategy Report
- Understand Genentech USA Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Genentech USA Catalyst Calendar
Proactively evaluate Genentech USA Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Genentech USA Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
06 Sep 2019 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
04 Sep 2019 | Regulatory Approval (EU) | Genentech USA Inc | - | polatuzumab vedotin | Oncology | Diffuse Large B-Cell Lymphoma | GD Estimates |
01 Sep 2019 | Phase II Trial Initiation | Fox Chase Cancer Center; Genentech USA Inc; National Comprehensive Cancer Network | - | atezolizumab | Oncology | Non-Small Cell Lung Cancer; Non-Small Cell Lung Carcinoma | Clinical Trial Registry |
01 Sep 2019 | Phase II Trial Initiation | F. Hoffmann-La Roche Ltd; Genentech USA Inc; Infinity Pharmaceuticals Inc | INFI; ROG | atezolizumab; bevacizumab; eganelisib | Oncology | Breast Cancer; Metastatic Renal Cell Carcinoma; Renal Cell Carcinoma; Triple-Negative Breast Cancer (TNBC) | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer